|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2005-9-26
|
|
pubmed:abstractText |
Salmeterol is a beta2-adrenoreceptor agonist used in the treatment of obstructive pulmonary disease. Salmeterol inhibits inflammatory responses by neutrophils and mononuclear cells in vitro and in mouse models of lung inflammation in vivo.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1073-449X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
172
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
878-84
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15994467-Adrenergic beta-Agonists,
pubmed-meshheading:15994467-Adult,
pubmed-meshheading:15994467-Albuterol,
pubmed-meshheading:15994467-Blood-Air Barrier,
pubmed-meshheading:15994467-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:15994467-Flow Cytometry,
pubmed-meshheading:15994467-Humans,
pubmed-meshheading:15994467-Lipopolysaccharides,
pubmed-meshheading:15994467-Lung,
pubmed-meshheading:15994467-Macrophages, Alveolar,
pubmed-meshheading:15994467-Male,
pubmed-meshheading:15994467-Neutrophil Infiltration,
pubmed-meshheading:15994467-RNA, Messenger,
pubmed-meshheading:15994467-Tumor Necrosis Factor-alpha,
pubmed-meshheading:15994467-Up-Regulation
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Antiinflammatory effects of salmeterol after inhalation of lipopolysaccharide by healthy volunteers.
|
|
pubmed:affiliation |
Department of Experimental Internal Medicine, Academic Medical Center, University of Amsterdam, The Netherlands. n.a.maris@amc.uva.nl
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
